Asperger's syndrome

Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Risk factors

By Mayo Clinic staff

Boys are far more likely to develop Asperger's syndrome than are girls.

References
  1. Asperger's disorder. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Arlington, Va.: American Psychiatric Association; 2000. http://psychiatryonline.com/content.aspx?aID=7667&searchStr=asperger%27s+disorder. Accessed Sept. 10, 2010.
  2. Toth K, et al. Asperger's syndrome: Diagnosis and treatment. American Journal of Psychiatry. 2008;165:958.
  3. Autism spectrum disorders. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec19/ch299/ch299c.html#S19_CH299_T002. Accessed Sept. 11, 2010.
  4. Asperger syndrome fact sheet. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/asperger/detail_asperger.htm?css=print. Accessed Sept 11, 2010.
  5. Notordaeme M, et al. Asperger's syndrome and high-functioning autism: Language, motor and cognitive profiles. European Child and Adolescent Psychiatry. 2010;19:475.
  6. Asperger syndrome. National Institute of Child Health and Human Development. http://www.nichd.nih.gov/health/topics/asperger_syndrome.cfm. Accessed Sept. 11, 2010.
  7. Weber K. Asperger's syndrome: From hiding to thriving. The Nurse Practitioner. 2008;19:14.
  8. Levy SE, et al. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatry Clinics of North America. 2008;17:803.
  9. Price CS, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126:656.
  10. Atkinson DL (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 25, 2010.
  11. Stigler KA, et al. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, perspective, open-label study. Journal of Child and Adolescent Psychopharmacology. 2009;19:265.
  12. Posey DJ, et al. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: A retrospective analysis of 80 cases. Journal of Child and Adolescent Psychopharmacology. 2004;14:233.
  13. Moreno C, et al. Metabolic effects of second-generation antipsychotics in bipolar youth: Comparison with other psychotic and nonpsychotic diagnoses. Bipolar Disorders. 2010;12:172.
  14. Malone RP, et al. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs. 2005;19:923.
  15. Elchaar GM, et al. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Annals of Pharmacotherapy. 2006;40:1086.
  16. Questions and answers on unapproved chelation products. Food and Drug Administration. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/ucm229313.htm. Accessed Oct. 26, 2010.
  17. Guastella AJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry. 2010;67:692.
  18. Hollander E, et al. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 2007;61:498.
DS00551 Nov. 18, 2010

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger